Sanofi Detailed Consensus >> Business P&L
Last Update: 2020-07-01

Please note: The P&L and the divisions show the restated Q2 2019 and FY 2019 numbers, including the sale of the equity investment in Regeneron.

KPI[EUR m]Q2 2019FY 2019Q2 2020 EFY 2020 EFY 2021 EFY 2022 EFY 2023 EFY 2024 E
Net salesNumber of Estimates121717171717
Net salesHighest8,62837,89540,37543,05945,72148,969
Net salesConsensus (Mean)8,62836,1268,34137,01038,91740,86341,87343,317
Net salesLowest8,09736,50337,71439,26840,01440,340
Other revenuesNumber of Estimates121717171717
Other revenuesHighest3821,6151,6661,7541,8361,960
Other revenuesConsensus (Mean)3521,5053431,5191,5721,6121,6531,698
Other revenuesLowest2611,2991,3341,3741,4121,470
Cost of salesNumber of Estimates121717171717
Cost of salesHighest-2,468-11,582-11,764-11,964-12,031-12,110
Cost of salesConsensus (Mean)-2,767-11,973-2,686-12,167-12,529-12,934-13,208-13,561
Cost of salesLowest-2,814-12,810-13,228-13,879-14,494-15,275
Gross ProfitNumber of Estimates121717171717
Gross ProfitHighest6,23326,85628,89230,93533,06335,601
Gross ProfitConsensus (Mean)6,21325,6585,99826,36227,95929,54130,31831,454
Gross ProfitLowest5,71625,94927,12728,46029,06329,442
- as % of net sales (gross margin)Number of Estimates121717171717
- as % of net sales (gross margin)Highest74.372.673.273.973.874.1
- as % of net sales (gross margin)Consensus (Mean)
- as % of net sales (gross margin)Lowest70.670.171.171.371.271.0
R&D expensesNumber of Estimates121717171717
R&D expensesHighest-1,360-5,744-5,832-5,936-5,749-5,485
R&D expensesConsensus (Mean)-1,587-6,018-1,483-5,980-6,063-6,118-6,136-6,210
R&D expensesLowest-1,617-6,095-6,308-6,408-6,504-6,766
SG&A expensesNumber of Estimates121717171717
SG&A expensesHighest-2,233-9,458-9,472-9,301-9,255-9,255
SG&A expensesConsensus (Mean)-2,459-9,883-2,355-9,735-9,831-9,908-9,971-10,089
SG&A expensesLowest-2,524-9,926-10,320-10,425-10,799-11,245
Other current operating income/expenseNumber of Estimates121717171717
Other current operating income/expenseHighest-72-505-805-1,101-1,387-1,640
Other current operating income/expenseConsensus (Mean)-91-382-188-875-1,303-1,738-2,131-2,468
Other current operating income/expenseLowest-263-1,165-1,796-2,337-2,695-3,043
Share of profit/loss of associatesNumber of Estimates121717171717
Share of profit/loss of associatesHighest1345566227659181,010
Share of profit/loss of associatesConsensus (Mean)7999407427476519551
Share of profit/loss of associatesLowest-23-91-81-61-41-21
Net income attributable to non-controlling interestsNumber of Estimates121717171717
Net income attributable to non-controlling interestsHighest-5-29-28-21-22-6
Net income attributable to non-controlling interestsConsensus (Mean)-5-35-8-37-36-35-35-34
Net income attributable to non-controlling interestsLowest-13-50-50-45-45-45
Business operating incomeNumber of Estimates121717171717
Business operating incomeHighest2,41810,41012,14413,31514,72716,693
Business operating incomeConsensus (Mean)2,0789,3492,06410,14211,15312,21812,56313,205
Business operating incomeLowest1,7619,66410,43111,13511,50011,579
- as % of net sales (operating margin)Number of Estimates121717171717
- as % of net sales (operating margin)Highest29.428.230.130.932.234.1
- as % of net sales (operating margin)Consensus (Mean)24.125.924.827.428.729.930.030.4
- as % of net sales (operating margin)Lowest21.625.927.328.428.728.4
Financial income & expenseNumber of Estimates121717171717
Financial income & expenseHighest-69-222-160-110-4626
Financial income & expenseConsensus (Mean)-96-303-84-303-272-242-206-169
Financial income & expenseLowest-110-360-397-378-376-377
- % tax rateNumber of Estimates121717171717
- % tax rateHighest-21.9-21.3-21.4-20.6-20.5-20.3
- % tax rateConsensus (Mean)-22.0-22.0-22.4-22.0-22.0-21.9-21.9-21.9
- % tax rateLowest-25.8-23.1-23.1-22.5-22.1-22.1
Business net incomeNumber of Estimates121717171717
Business net incomeHighest1,8408,0079,35110,35911,52913,166
Business net incomeConsensus (Mean)1,5467,0501,5577,7618,5779,4529,76110,301
Business net incomeLowest1,3247,3597,9418,5118,8209,088
- as % of net sales (net profit margin)Number of Estimates121717171717
- as % of net sales (net profit margin)Highest22.421.923.
- as % of net sales (net profit margin)Consensus (Mean)17.919.518.721.
- as % of net sales (net profit margin)Lowest16.119.520.721.722.021.8
Number of sharesNumber of Estimates121616161616
Number of sharesHighest1,2561,2551,2561,2561,2571,258
Number of sharesConsensus (Mean)1,2491,2501,2511,2511,2481,2461,2421,238
Number of sharesLowest1,2441,2461,2401,2201,1831,134
Business EPS (in EUR)Number of Estimates121818181717
Business EPS (in EUR)Highest1.476.537.478.279.2110.51
Business EPS (in EUR)Consensus (Mean)1.245.641.246.226.877.567.868.32
Business EPS (in EUR)Lowest1.055.906.396.897.197.25
Dividend Per Share (in EUR)Number of Estimates-1313131212
Dividend Per Share (in EUR)Highest-3.403.744.104.354.88
Dividend Per Share (in EUR)Consensus (Mean)-3.15-3.263.473.723.914.14
Dividend Per Share (in EUR)Lowest-

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.